For a patient already on a statin, adding semaglutide may produce additional lipid improvements beyond what the statin alone is achieving
Wegovy, which contains the same active ingredient at a higher dose, is the approved semaglutide option specifically indicated for chronic weight management
administrado mediante inyeccin subcutnea 1 vez al da, en cualquier momento del da, con independencia de las comidas)
Targeting PI3K/AKT and MEK/ERK pathways for synergic effects on improving features of peripheral diabetic neuropathy
It typically lasts between 30 and 90 days, but you must adhere to the specific Beyond-Use Date (BUD) printed on your vial's label by the compounding pharmacy
Howard Shapiro's approach is whole-person: medical oversight + nutrition strategy + behavior support for sustainable, long-term results